Skip to content
FIND A HEALTH VALLEY ACTOR

CHF 870 Million invested in Swiss medtech and biotech companies

Swiss Venture Capital Report

In the midst of an unfavourable environment, the life sciences’ sector continues to attract investors in Switzerland according to the Swiss Venture Capital Report 2024.     In 2023, the downturn on the global venture capital market reached Switzerland. Swiss startups received a total of CHF 2.6 Billion last year, 35% less than in 2022.…

Read More

Lonza Achieves Strong Financial Results in 2023 Amid Leadership Transition

Lonza Visp

The Swiss CDMO announces robust sales of CHF 6.7 billion, delivering 10.9%1 CER sales growth, and the nomination of Jean-Marc Huët to succeed Albert M. Baehny as chairman of the company.     Lonza, a leading CDMO (Contract Development and Manufacturing Organization), has reported robust financial results for the year 2023. The company achieved sales…

Read More

Stämm chooses Valais to set up its European team

Stämm

The Argentinian biomanufacturing innovator is launching its R&D facility at the BioArk in Monthey     Founded in 2016 in Argentina, Stämm, now boasting a robust team of over 200 in Buenos Aires and San Francisco, specializes in harnessing nature-inspired, data-driven solutions to revolutionize bioprocessing. With the establishment of its new R&D facility in Western…

Read More

Calypso enters into agreement to be acquired by Novartis

Novartis - Calypso

Calypso’s shareholders will receive an upfront payment of $250 Million upon closing and are eligible to receive up to $175 Million based on the achievement of certain predetermined milestones. Calypso is a leader in the development of Interleukin15 (IL-15) targeted therapies.     Calypso, a spin-out from Merck based in Plan-Les-Ouates (Geneva), is focused on…

Read More

Kickfund Ventures: CHF 70 Million for Swiss deeptech startups

Kickfund Venture

The fund, backed by a diverse group of investors, including anchor investors Ernst Göhner Stiftung and Gebert Rüf Stiftung, will provide up to CHF 850,000 per company to Venture Kick alumni. Qualified investors might still be accepted to the partnership.   The unique concept of the Kickfund is based on many years of experience and successful…

Read More

4 life sciences projects supported by the FIF

Fongit Innovation Fund

Four Geneva-based technology projects have won funding from the Fongit Innovation Fund (FIF) for their innovations. A seed loan of CHF 100,000 has been granted to Carrat Sàrl. Three grants of CHF 50,000 have been awarded to each of the following: iSleep, LaxiPed and Pneumoscope.     Seed loan of CHF 100,000 awarded to Carrat…

Read More

Vandria Announces a CHF 18 Million Fundraising

Vandria

The $20.6M (CHF 18M) round was led by ND Capital together with a small syndicate of HNW private investors. The Vaud-based start-up develops mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases     Vandria was spun out of Amazentis SA in 2021 with backing by ND Capital to develop first-in-class small molecule mitophagy…

Read More

Haleon awarded by the Prix Vaudois des Entreprises Internationales (PVEI)

Haleon PVEI

Haleon, a former division of GSK that became independent in 2022, won the jury’s award in the “Foreign company” category.     Haelon was born in July 2022 and is the new company resulting from the spin-off of the consumer healthcare branch of the pharmaceutical laboratory Glaxosmithkline (UK). The young company holds a portfolio of…

Read More

Dr. Madiha Derouazi becomes AC Immune’s CSO

AC Immune

Dr. Madiha Derouazi is the founder of the Swiss biotech AMAL Therapeutics and the former CEO of German-based company Speransa Therapeutics. She is an internationally well-known and recognised immunologist, entrepreneur, and vaccine developer. Her experience will help AC Immune become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease.     AC…

Read More

A CHF 2.5 Million Grant for Diatheris

Diatheris 1

The Leona M. and Harry B. Helmsley Charitable Trust in the United States supports the Diatheris project, a UNIGE spin-off working on an adjunct treatment to boost insulin therapy.     This funding will enable Giorgio Ramadori, a researcher in the Department of Cell Physiology and Metabolism and the Faculty Centre for Diabetes in the…

Read More